Oral Spironolactone for Acne Vulgaris in Adult Females: A Hybrid Systematic Review
Open Access
- 2 February 2017
- journal article
- review article
- Published by Springer Nature in American Journal of Clinical Dermatology
- Vol. 18 (2) , 169-191
Abstract
Background The management of acne in adult females is problematic, with many having a history of treatment failure and some having a predisposition to androgen excess. Alternatives to oral antibiotics and combined oral contraceptives (COCs) are required. Objective Our aim was to conduct a hybrid systematic review of the evidence for benefits and potential harms of oral spironolactone in the management of acne in adult females. Methods The review was conducted according to a previously published protocol. Three reviewers independently selected relevant studies from the search results, extracted data, assessed the risk of bias, and rated the quality of the evidence using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach. Results Ten randomized controlled trials (RCTs) and 21 case series were retrieved. All trials were assessed as being at a ‘high risk’ of bias, and the quality of evidence was rated as low or very low for all outcomes. Apart from one crossover trial that demonstrated statistical superiority of a 200 mg daily dose versus inflamed lesions compared with placebo, data from the remaining trials were unhelpful in establishing the degree of efficacy of lower doses versus active comparators or placebo. Menstrual side effects were significantly more common with the 200 mg dose; frequency could be significantly reduced by concomitant use of a COC. Pooling of results for serum potassium supported the recent recommendation that routine monitoring is not required in this patient population. Conclusion This systematic review of RCTs and case series identified evidence of limited quality to underpin the expert endorsement of spironolactone at the doses typically used (≤100 mg/day) in everyday clinical practice.Keywords
This publication has 105 references indexed in Scilit:
- Flutamide versus a cyproterone acetate-ethinyl estradiol combination in moderate acne: a pilot randomized clinical trialClinical, Cosmetic and Investigational Dermatology, 2011
- Profile of acne vulgaris-A hospital-based study from South IndiaIndian Journal of Dermatology, Venereology and Leprology, 2009
- Efficacy and tolerance of acne treatment using both spironolactone and a combined contraceptive containing drospirenoneJournal of the American Academy of Dermatology, 2008
- How to formulate research recommendationsBMJ, 2006
- The effect of a phasic oral contraceptive containing Desogestrel on seborrhea and acneThe European Journal of Contraception & Reproductive Health Care, 2006
- Effects and side‐effects of spironolactone therapy in women with acneJournal of the European Academy of Dermatology and Venereology, 2005
- Long-Term Safety of Spironolactone in Acne: Results of an 8-Year Followup StudyJournal of Cutaneous Medicine and Surgery, 2002
- SpironolactoneJournal of the American Academy of Dermatology, 1992
- Spironolactone in dermatologic therapyJournal of the American Academy of Dermatology, 1991
- LACK OF EFFECT OF CIMETIDINE IN ACNEThe Lancet, 1980